Showing 25 - 48 of 103 results
Previous| 1 | 2 | 3 ...5 |Next
Milestone Study Shows Psychedelic Treatment with Psilocybin Relieves Major Depression
Psychedelics Research and Psilocybin Therapy
Psychedelic Treatment with Psilocybin Relieves Major Depression, Study Shows
Achieving 'Balance': How a Johns Hopkins Program Boosts Corporate Mental Health
Diversity by Race, Ethnicity, and Sex within the US Psychiatry Physician Workforce
‘New Terrain’: Psychiatrist Opens Up About Caring for Patients Recovering from COVID-19
Gearing Up for COVID-19’s Mental Health Toll
Treating Substance Use Disorder During COVID-19
Gene Reveals Itself As Key Epigenetic Regulator in Neurodevelopmental Disorders
First-of-Its Kind Psychedelic Research Center Debuts at Johns Hopkins
Genetic Syndrome of Intellectual Disability Fixed in Mice Using Precision Epigenome Editing
Bob Roca's Back-to-the-Future Moment
Why Defining Impulsive/Reactive Aggression in Youth Matters
Using Big Data to Decode Alzheimer’s Disease
Some CBD Products May Yield Cannabis-Positive Urine Drug Tests
Lab Studies Dive Headfirst into Pathways Touched by Schizophrenia
Low-Cost Intervention Reduces Risk of Opioid Overdose
Esketamine: A New Approach for Patients with Treatment-Resistant Depression
Johns Hopkins Launches Center For Psychedelic Research
High Fat Diet During Pregnancy Slows Learning in Offspring, Rat Study Suggests
Deep Brain Stimulation Eases Parkinson’s Disease Symptoms by Boosting Dopamine
‘Stressors’ In Middle Age Linked To Cognitive Decline In Older Women
Study Suggests Overdiagnosis of Schizophrenia
Research Roundup: New Studies on Insomnia, Buprenorphine and More